ALDH2
Aldehyde dehydrogenase, mitochondrial
As of the edition of 20 October 2026, ALDH2 (aldehyde dehydrogenase, mitochondrial, UniProt P05091) has 2 drugs tested at it and 3 companies on the list, 1 on route A and 1 on route B.
Sources: UniProt, ClinicalTrials.gov, ChEMBL, FDA Orange Book and Purple Book, Pharos.
The protein
- UniProt
- P05091
- How well studied
- Drug target: an approved drug acts on it
- Where it sits in the cell
- Inside the cell
- Solved structures
- 29
- Disease areas
- Cancer; Chemically induced; Mental health; Infections; Immune system; Skin and connective tissue; Urinary and reproductive; Lungs and airways
- Registered trials of its drugs
- 53
Drugs at this target
| Status | Count |
|---|---|
| Marketed | 1 |
| Went quiet | 1 |
| Total | 2 |
| Drug | Status | Furthest phase | US protection |
|---|---|---|---|
| Disulfiram | Marketed | Phase 4 | none listed |
| ANS-6637 | Went quiet | Phase 2 | none listed |
2 of 2 drugs, the most tested first.
Companies at this target
| Where the company stands | Companies |
|---|---|
| Route A | 1 |
| Route B | 1 |
| Undetermined | 1 |
| Total on the list | 3 |
| Company | Route |
|---|---|
| Stallergenes | Route B |
| Amygdala Neurosciences | Route A |
The other 1 company at ALDH2
In the product3 companies in all; 1 is not named here, and no score is.
See the 3 companies at ALDH2, ranked, with the facts behind eachRequest access. Nothing is shown until you do.